Telomeres as targets for anticancer therapies
- 3 February 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 15 (5) , 579-593
Abstract
(2011). Telomeres as targets for anticancer therapies. Expert Opinion on Therapeutic Targets: Vol. 15, No. 5, pp. 579-593.Keywords
This publication has 92 references indexed in Scilit:
- Telomere biology in MetazoaFEBS Letters, 2010
- Telomeres: Structures in need of unwindingFEBS Letters, 2010
- Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomerBiochemical Pharmacology, 2010
- Human RAP1 inhibits non‐homologous end joining at telomeresThe EMBO Journal, 2009
- A G-quadruplex Stabilizer Induces M-phase Cell Cycle ArrestJournal of Biological Chemistry, 2009
- Formation of a Unique End-to-End Stacked Pair of G-Quadruplexes in the hTERT Core Promoter with Implications for Inhibition of Telomerase by G-Quadruplex-Interactive LigandsJournal of the American Chemical Society, 2009
- Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathwayNucleic Acids Research, 2009
- Targeting Human Gastrointestinal Stromal Tumor Cells with a Quadruplex-Binding Small MoleculeJournal of Medicinal Chemistry, 2009
- Targeting the telosome: Therapeutic implicationsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Telomere dysfunction and tumour suppression: the senescence connectionNature Reviews Cancer, 2008